Keyword: BioClinica

After $160M Medpace IPO, Cinven buys Bioclinica

The $14 billion deal that will see Pfizer buy out Californian cancer biotech Medivation might be hitting the headlines this week, but after weeks of speculation the clinical trial services firm Bioclinica has now seen a major merger of its own.